Health Condition 1: E660- Obesity due to excess calories
Conditions
Interventions
Intervention1: Women centric weight management module: Women centric weight management program for 6 months with intensive counselling sessions on diet, phyical activity and behavioral modification te
Sponsors
Department of science and technology DST
Eligibility
Inclusion criteria
Inclusion criteria: Group A: Postpartum women i. Women aged between 25-35 years. ii. Women in the postpartum period from 6 weeks to 6 months post-delivery, after 37 week pregnancy term through a normal or C-section delivery. iii. Women who gave singleton birth. iv. BMI between >= 25 to v. Women who can provide a history of pre-pregnancy weight and gestational weight gain (3, 6 and 9 months) as medical record or recall. vi. Women who can read in Hindi/ English. vii. Women who will be lactating. Group B: Perimenopausal women i. Menopausal women aged between 40-55 years. ii. Women with an intact uterus, >= 1 functioning ovary and >=1 menstrual period in past 12 months. iii. BMI between >= 26 to iv. Women who can read in Hindi/ English. v. Intend to follow up regularly will be included in the study. vi. The ownership or accessibility to mobile phones for technology based intervention.
Exclusion criteria
Exclusion criteria: Group A: Postpartum women i) Women with pregnancy related complications (pre-eclampsia, pre-term, hemorrhage, infection). ii) Patients with secondary causes of obesity (like Hypothyroidism, Cushingâ??s diseases, PCOS). iii) Acute infections, advanced end-organ damage or chronic diseases: renal/ hepatic failure, any malignancy iv) Current intake of medicine known to affect body weight such as drugs acting on the central nervous system, cathartics, thyroid supplements, diuretics and selective serotonin reuptake inhibitors. v) Psychosocial contraindications such as bulimia nervosa, anorexia nervosa, substance abuse, clinically significant depression or under current psychiatric care. Group B: Perimenopausal women i. Women using oral or injectable hormonal contraception, tamoxifen, tibolone and raloxifene in the previous 3 months. ii. Patients with secondary causes of obesity (like Hypothyroidism, Cushingâ??s diseases, PCOS). iii. Acute infections, advanced end-organ damage or chronic diseases: renal/ hepatic failure, any malignancy. iv. Current intake of medicine known to affect body weight such as drugs acting on the central nervous system, cathartics, thyroid supplements, diuretics and selective serotonin reuptake inhibitors. v.Psychosocial contraindications such as bulimia nervosa, anorexia nervosa, substance abuse, clinically significant depression or under current psychiatric care. vi. Planning to move out within the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight loss post treatment.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 2.Change in Biochemical parameters fasting blood glucose, lipid profile, fasting insulin, Body Composition Analysis after six months of enrolment.Timepoint: 6 month. | — |
Countries
India
Contacts
Public ContactDr Piyush Ranjan
All India Institute of Medical Sciences New Delhi
Outcome results
None listed